Search results
AbbVie's Skyrizi Gets FDA Approval to Treat Certain Instances of Ulcerative Colitis
Market Watch· 6 days agoPublished: June 18, 2024 at 6:36 p.m. ETShareResizeBy Sabela OjeaAbout Dow Jones NewswiresDow Jones Newswires is a market-moving financial and business news source, used by wealth managers, ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 5 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
J&J (JNJ) Seeks Expanded Use of Tremfya for Crohn's Disease
Zacks via Yahoo Finance· 4 days agoJ&J (JNJ) seeks label expansion for Tremfya for treating moderately to severely active Crohn's...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 5 days agoWith the nod from the FDA, Skyrizi joins Rinvoq as immunology drugs in the AbbVie pipeline approved for both IBD conditions, UC and Crohn's. With the arrival of biosimilar ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 5 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug ...
2 Super Smart Dividend Stocks to Buy With $10,000 Right Now
Motley Fool via Yahoo Finance· 6 days agoHumira sales have dropped considerably and will continue to fall due to the lower-priced options....
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Tri-County Times· 6 days agoAbbVie logo (PRNewsFoto/AbbVie)
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 7 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
10 things to watch in the stock market Tuesday including Nvidia price-target hikes
CNBC· 7 days agoMy top 10 things to watch Tuesday, June 18 Markets are poised for a subdued open Tuesday following a...
Drug names: How companies and regulators come up with hundreds of new names every year
Quartz· 5 days agoEverything you need to know about the art and science of drug naming in five minutes or less,...